KRSA 8-K 2026-09-11
Korsana Biosciences, Inc. (KRSA) 8-K dated 2026-09-11 — accession 0001193125-26-389318.
Korsana Biosciences, Inc. (KRSA) common stock.
CYCN to acquire platform ($380M)
This 8-K covers: Material agreement (Item 1.01), Acquisition or disposition (Item 2.01), Results of operations (Item 2.02), Unregistered share sale (Item 3.02), Change to holders' rights (Item 3.03), Change in control (Item 5.01). SEC EDGAR holds the official filing and its exhibits.
Income-statement cache for KRSA is thin on this filing URL. We will not invent exhibit numbers.
Not investment advice. The KRSA SEC hub lists recent forms. The stock page is the research view.
- Guidance
- expects,” “intends,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “projects,” “seeks,” “target,” “endeavor,” “p
- Deal
- $380M
Why it matters
- expects,” “intends,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “projects,” “seeks,” “target,” “endeavor,” “p
- Transaction value about $380M